PDS Biotech Receives $1.4 Million After Selling Its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Program
24 avr. 2023 08h00 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., April 24, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
Elevar Therapeutics Presents AACR 2023 Poster Demonstrating Rivoceranib as Most Selective VEGFR-2 Inhibitor When Compared to Other TKIs With Known Activity Against VEGFR-2
18 avr. 2023 09h00 HE
|
Elevar Therapeutics
ORLANDO, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...
As a Breast Cancer Survivor, I've Seen Firsthand How Early Detection and Clinical Trial Initiatives Save Lives
14 avr. 2023 09h47 HE
|
National Women's Health Network
Washington D.C., April 14, 2023 (GLOBE NEWSWIRE) -- Diagnosed By Chance As the former Executive Director of the American Cancer Society, I can confidently say I’m cancer-literate. I get mammograms...
PDS Biotech to Host Interleukin 12 (IL-12) Immunocytokine-Focused KOL Roundtable on April 21, 2023
12 avr. 2023 08h00 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference
11 avr. 2023 08h30 HE
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., April 11, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced details relating to eight...
Global Interventional Oncology Devices Market Report 2023: Players Include Boston Scientific, Medtronic, Terumo, and Philips Volcano
30 mars 2023 10h18 HE
|
Research and Markets
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Amplified Sciences, Inc. revolutionizing early-detection diagnostics of pancreatic cancer and other diseases
14 mars 2023 08h00 HE
|
Purdue Research Foundation
WEST LAFAYETTE, INDIANA, March 14, 2023 (GLOBE NEWSWIRE) -- A series of early-detection diagnostic tests under development by a Purdue-sponsored startup may commute the death sentence often...
United in the Fight Against Colorectal Cancer
01 mars 2023 17h42 HE
|
Fight Colorectal Cancer
Springfield, Mo., March 01, 2023 (GLOBE NEWSWIRE) -- On the heels of the White House declaring March as Colorectal Cancer Awareness Month, urging the public to get screened, national advocacy...
Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound
10 févr. 2023 07h35 HE
|
Sunshine Biopharma Inc.
MONTREAL, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the ASCO GU Cancer Symposium
25 janv. 2023 07h00 HE
|
Theralase Technologies Inc.
TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...